The exercise period of TO4 starts August 25.

August 25 – September 8 2019 is exercise period of Brighter TO4 during which holders of the warrants can subscribe for shares. One (1) TO4 can be exchanged for one (1) share during the period, at a price of SEK 6.01.

Holders of warrants who have their warrants registered in custody at a bank or fund commissioner shall contact their bank or fund commissioner if they want to exercise the warrants and subscribe for the corresponding shares.

Exercise of the warrants and subscription of shares for other holders of warrants takes place through simultaneous payment and submittal of the registered application form (here), signed and submitted to the Company’s share agent (Eminova Fondkommission) no later than 16:00 CET on September 8, 2019.

In case of need of further assistance or questions, please contact the company’s share agent Eminova Fondkommission by phone 08-684 211 00 or by email info@eminova.se.

The two final TO4 exercise periods are:

  •  22 February – 8 March, 2020
  •  25 August – 8 September, 2020

For full terms and conditions, please visit Brighter’s website. 

For further information, please contact:

Henrik Norström, CEO   
Phone: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se

About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.sewww.eminova.se.

About Us

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Visit our website: https://brighter.se/. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links